FDAnews
www.fdanews.com/articles/122640-first-subject-dosed-in-phase-ib-trial-of-oxycodone-patch

First Subject Dosed in Phase Ib Trial of Oxycodone Patch

December 2, 2009
Phosphagenics Limited Wednesday announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.
Fox Business